Literature DB >> 8811457

Determination of sumatriptan succinate in human plasma by high-performance liquid chromatography with coulometric detection and utilization of solid-phase extraction.

M Franklin1, J Odontiadis, E M Clement.   

Abstract

Sumatriptan succinate (the analyte) and naloxone (the internal standard) were extracted from plasma with a solid-phase extraction technique. Chromatography and detection were performed by isocratic reversed-phase high-performance liquid chromatography with coulometric end-point detection. The standard curve was linear over the range 0-100 ng/ml of sumatriptan succinate in plasma. The reproducibility (as defined by the coefficient of variation, C.V.) over the range of the standard curve was 4.9-7.3%. The recovery averaged 83%. The sensitivity was 0.25 ng of sumatriptan on column (allowing a concentration of 0.5 ng/ml to be determined from a 1-ml plasma sample volume). Plasma profiles of the analyte following subcutaneous (s.c.) administration in eight normal male volunteers, are presented.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8811457     DOI: 10.1016/0378-4347(96)00040-0

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  3 in total

1.  Development and Validation of a HPTLC Method for the Estimation of Sumatriptan in Tablet Dosage Forms.

Authors:  C R Shah; B N Suhagia; N J Shah; R R Shah
Journal:  Indian J Pharm Sci       Date:  2008-11       Impact factor: 0.975

2.  Development and Validation of Liquid Chromatography-Tandem Mass Spectrometry Method for Simple Analysis of Sumatriptan and its Application in Bioequivalence Study.

Authors:  Wisut Wichitnithad; Siriwan Nantaphol; Petploy Vicheantawatchai; Thanyaporn Kiatkumjorn; Wachirasak Wangkangwan; Pornchai Rojsitthisak
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-24

3.  Utilization of N-bromosuccinimide as a brominating agent for the determination of sumatriptan succinate in bulk drug and tablets.

Authors:  Kudige N Prashanth; Kanakapura Basavaiah; Madihalli S Raghu
Journal:  Int J Anal Chem       Date:  2013-07-09       Impact factor: 1.885

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.